Citation Impact
Citing Papers
An Opportunity for Prevention
2004
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Department of Defense Prostate Cancer Clinical Trials Consortium: A New Instrument for Prostate Cancer Clinical Research
2009
PIASy, a nuclear matrix–associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies
2001
Are US Populations Appropriate for Trials of Human Immunodeficiency Virus Vaccine?
2001
Epidermal growth factor receptor tyrosine kinase
1994
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Regulation of gene-activation pathways by PIAS proteins in the immune system
2005
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
CD155/PVR plays a key role in cell motility during tumor cell invasion and migration
2004
Imaging the Glycosylation State of Cell Surface Glycoproteins by Two‐Photon Fluorescence Lifetime Imaging Microscopy
2013 StandoutNobel
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
2014 StandoutNature
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
DJ-1 Positively Regulates the Androgen Receptor by Impairing the Binding of PIASxα to the Receptor
2001
Sensitization of IFN-γ Jak-STAT signaling during macrophage activation
2002
Integrins in prostate cancer progression
2008
SUMO Modification of STAT1 and Its Role in PIAS-mediated Inhibition of Gene Activation
2003
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Involvement of PIAS1 in the Sumoylation of Tumor Suppressor p53
2001
New Therapeutics to Treat Castrate‐Resistant Prostate Cancer
2013
Transcription factor Sp3 is silenced through SUMO modification by PIAS1
2002
STAT1 as a key modulator of cell death
2006
Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
2009
Regulation of JAK–STAT signalling in the immune system
2003
Prevention of Venous Thromboembolism
2004 Standout
Emerging Biological Principles of Metastasis
2017 Standout
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Teaching Surgical Skills — Changes in the Wind
2006 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
EMT: 2016
2016 Standout
Targeting metastasis
2016
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Increased K+ Efflux and Apoptosis Induced by the Potassium Channel Modulatory Protein KChAP/PIAS3β in Prostate Cancer Cells
2002
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Stat1-dependent and -independent pathways in IFN-γ-dependent signaling
2002
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
The Educational Impact of Bench Model Fidelity on the Acquisition of Technical Skill
2004
Cytokine Signaling in 2002
2002 Standout
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Protein Inhibitors of Activated STAT Resemble Scaffold Attachment Factors and Function as Interacting Nuclear Receptor Coregulators
2002
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Reassessment of Exosome Composition
2019 Standout
Induction of Apoptosis by Protein Inhibitor of Activated Stat1 through c-Jun NH2-terminal Kinase Activation
2001
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Exploring the full spectrum of macrophage activation
2008 Standout
The first five years of single-cell cancer genomics and beyond
2015
Non-Invasive PET Imaging of EGFR Degradation Induced by a Heat Shock Protein 90 Inhibitor
2007
Pathogen Recognition and Innate Immunity
2006 Standout
Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine
2011
Making sense of the meaning literature: An integrative review of meaning making and its effects on adjustment to stressful life events.
2010 Standout
A review of tasquinimod in the treatment of advanced prostate cancer
2013
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
2009 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Synthesis, Characterization, and Cytotoxicity of a Novel Highly Charged Trinuclear Platinum Compound. Enhancement of Cellular Uptake with Charge
2005
A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases
2001
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
2003 Standout
Functional Anthology of Intrinsic Disorder. 2. Cellular Components, Domains, Technical Terms, Developmental Processes, and Coding Sequence Diversities Correlated with Long Disordered Regions
2007
New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway
2011
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Identification and characterization of EGF receptor in individual exosomes by fluorescence‐activated vesicle sorting
2016
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Comparative Analysis of Transperineal Template Saturation Prostate Biopsy Versus Magnetic Resonance Imaging Targeted Biopsy with Magnetic Resonance Imaging-Ultrasound Fusion Guidance
2014
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity
2002
Current Status of Src Inhibitors in Solid Tumor Malignancies
2011
Protein Detection Enhanced by 3DNA Dendrimer Signal Amplification
2008
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT
2003
Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine
2007
PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription
2007
Protein Modification by SUMO
2004 Standout
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
2014
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxβ
2002
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
2003 StandoutScience
Inhibition of IFN-γ-Induced Class II Transactivator Expression by a 19-kDa Lipoprotein fromMycobacterium tuberculosis: A Potential Mechanism for Immune Evasion
2003
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
2004 Standout
Works of Mitchell E. Gross being referenced
Targeting the HER-kinase axis in cancer
2004
Predictors of affect following treatment decision‐making for prostate cancer: conversations, cognitive processing, and coping
2008
Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line
2012
Activity of second‐line chemotherapy in docetaxel‐refractory hormone‐refractory prostate cancer patients
2007
Protein partners of C/EBPε
2004
Phase II Evaluations of Cilengitide in Asymptomatic Patients with Androgen-Independent Prostate Cancer: Scientific Rationale and Study Design
2006
Once-daily Dasatinib: Expansion of Phase II Study Evaluating Safety and Efficacy of Dasatinib in Patients With Metastatic Castration-resistant Prostate Cancer
2011
Rapid Phenotypic and Genomic Change in Response to Therapeutic Pressure in Prostate Cancer Inferred by High Content Analysis of Single Circulating Tumor Cells
2014
Anterior gradient 2 (AGR2): Blood‐based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype
2012
PIASy-mediated repression of the androgen receptor is independent of sumoylation
2004
Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells
2001
3-Dimensional Elastic Registration System of Prostate Biopsy Location by Real-Time 3-Dimensional Transrectal Ultrasound Guidance With Magnetic Resonance/Transrectal Ultrasound Image Fusion
2012
Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
2009
A transcriptional corepressor of Stat1 with an essential LXXLL signature motif
2001
The ethical allocation of scarce resources in surgery: implants and cost.
1997
EMD121974 (NSC 707544, cilengitide) in asymptomatic metastatic androgen independent prostate cancer (AIPCa) patients (pts): A randomized trial by the Prostate Cancer Clinical Trials Consortium (NCI 6372)
2007
HIV and hepatitis B infection and risk behavior in young gay and bisexual men.
1997
β-2-Microglobulin Is an Androgen-Regulated Secreted Protein Elevated in Serum of Patients with Advanced Prostate Cancer
2007
Venous thromboembolism prophylaxis after total hip or knee arthroplasty: a survey of Canadian orthopedic surgeons.
1999
Safety, efficacy, and pharmacodynamics of the investigational agent orteronel (TAK-700) in metastatic castration-resistant prostate cancer (mCRPC): Updated data from a phase I/II study.
2012
Detection of Androgen Receptor Mutations in Circulating Tumor Cells in Castration-Resistant Prostate Cancer
2010
Clinical outcome of taxane-resistant (TR) hormone refractory prostate cancer (HRPC) patients (pts) treated with subsequent chemotherapy (ixabepilone (Ix) or mitoxantrone/prednisone (MP)
2006
Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient.
1991